252 related articles for article (PubMed ID: 32738062)
21. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
[TBL] [Abstract][Full Text] [Related]
22. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.
Rosenberg PB; Mielke MM; Appleby BS; Oh ES; Geda YE; Lyketsos CG
Am J Geriatr Psychiatry; 2013 Jul; 21(7):685-95. PubMed ID: 23567400
[TBL] [Abstract][Full Text] [Related]
23. Association of arterial stiffness with cognition in patients with Lewy body disorder.
Ryu DW; Kim JS; Lee JE; Park JW; Oh YS; An JY; Lee KS
Neurol Sci; 2017 Jul; 38(7):1307-1313. PubMed ID: 28474150
[TBL] [Abstract][Full Text] [Related]
24. Persisting neuropsychiatric symptoms, Alzheimer's disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate.
Ouanes S; Rabl M; Clark C; Kirschbaum C; Popp J
Alzheimers Res Ther; 2022 Dec; 14(1):190. PubMed ID: 36529757
[TBL] [Abstract][Full Text] [Related]
25. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.
Kraybill ML; Larson EB; Tsuang DW; Teri L; McCormick WC; Bowen JD; Kukull WA; Leverenz JB; Cherrier MM
Neurology; 2005 Jun; 64(12):2069-73. PubMed ID: 15985574
[TBL] [Abstract][Full Text] [Related]
26. Prospective predictors of decline
Hamilton CA; Matthews FE; Donaghy PC; Taylor JP; O'Brien JT; Barnett N; Olsen K; McKeith IG; Thomas AJ
Psychol Med; 2021 Nov; 51(15):2590-2598. PubMed ID: 32366348
[TBL] [Abstract][Full Text] [Related]
27. Trajectories of cognitive decline in different types of dementia.
Smits LL; van Harten AC; Pijnenburg YA; Koedam EL; Bouwman FH; Sistermans N; Reuling IE; Prins ND; Lemstra AW; Scheltens P; van der Flier WM
Psychol Med; 2015 Apr; 45(5):1051-9. PubMed ID: 25229325
[TBL] [Abstract][Full Text] [Related]
28. Serum Potassium Is Associated with Cognitive Decline in Patients with Lewy Body Dementia.
Giil LM; Solvang SH; Giil MM; Hellton KH; Skogseth RE; Vik-Mo AO; Hortobágyi T; Aarsland D; Nordrehaug JE
J Alzheimers Dis; 2019; 68(1):239-253. PubMed ID: 30775974
[TBL] [Abstract][Full Text] [Related]
29. The course of depressive symptoms in Lewy body dementia and Alzheimer's disease.
Römer B; Dalen I; Ballard C; Aarsland D
J Affect Disord; 2023 Jul; 333():459-467. PubMed ID: 37105470
[TBL] [Abstract][Full Text] [Related]
30. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
[TBL] [Abstract][Full Text] [Related]
31. Paired Studies Comparing Clinical Profiles of Lewy Body Dementia with Alzheimer's and Parkinson's Diseases.
Scharre DW; Chang SI; Nagaraja HN; Park A; Adeli A; Agrawal P; Kloos A; Kegelmeyer D; Linder S; Fritz N; Kostyk SK; Kataki M
J Alzheimers Dis; 2016 Oct; 54(3):995-1004. PubMed ID: 27567844
[TBL] [Abstract][Full Text] [Related]
32. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
Dietlin S; Soto M; Kiyasova V; Pueyo M; de Mauleon A; Delrieu J; Ousset PJ; Vellas B
J Alzheimers Dis; 2019; 70(1):25-34. PubMed ID: 31127783
[TBL] [Abstract][Full Text] [Related]
33. Serum TCA cycle metabolites in Lewy bodies dementia and Alzheimer's disease: Network analysis and cognitive prognosis.
Jaramillo-Jimenez A; Giil LM; Borda MG; Tovar-Rios DA; Kristiansen KA; Bruheim P; Aarsland D; Barreto GE; Berge RK
Mitochondrion; 2023 Jul; 71():17-25. PubMed ID: 37172667
[TBL] [Abstract][Full Text] [Related]
34. The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease.
Stavitsky K; Brickman AM; Scarmeas N; Torgan RL; Tang MX; Albert M; Brandt J; Blacker D; Stern Y
Arch Neurol; 2006 Oct; 63(10):1450-6. PubMed ID: 17030662
[TBL] [Abstract][Full Text] [Related]
35. Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.
Abdelnour C; van Steenoven I; Londos E; Blanc F; Auestad B; Kramberger MG; Zetterberg H; Mollenhauer B; Boada M; Aarsland D;
Mov Disord; 2016 Aug; 31(8):1203-8. PubMed ID: 27296778
[TBL] [Abstract][Full Text] [Related]
36. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
[TBL] [Abstract][Full Text] [Related]
37. Neuropsychological correlates of behavioral symptoms in Alzheimer's disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: a comparative study.
Perri R; Monaco M; Fadda L; Caltagirone C; Carlesimo GA
J Alzheimers Dis; 2014; 39(3):669-77. PubMed ID: 24254701
[TBL] [Abstract][Full Text] [Related]
38. Clinical Lewy body dementia and the impact of vascular components.
Londos E; Passant U; Brun A; Gustafson L
Int J Geriatr Psychiatry; 2000 Jan; 15(1):40-9. PubMed ID: 10637403
[TBL] [Abstract][Full Text] [Related]
39. Serum tyrosine is associated with better cognition in Lewy body dementia.
McCann A; Aarsland D; Ueland PM; Solvang SH; Nordrehaug JE; Giil LM
Brain Res; 2021 Aug; 1765():147481. PubMed ID: 33865805
[TBL] [Abstract][Full Text] [Related]
40. Hippocampal subfields and decline in activities of daily living in Alzheimer's disease and dementia with Lewy bodies.
Borda MG; Jaramillo-Jimenez A; Tovar-Rios DA; Ferreira D; Garcia-Cifuentes E; Vik-Mo AO; Aarsland V; Aarsland D; Oppedal K
Neurodegener Dis Manag; 2020 Dec; 10(6):357-367. PubMed ID: 32967534
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
